In the late 1950s, oil prices were not set by the countries that produced the oil, but by a handful of large Western companies that controlled production. When these companies unilaterally cut prices, shrinking the revenues of producing nations, frustration began to build across key exporters.
In 1960, that frustration led Iran, Iraq, Kuwait, Saudi Arabia and Venezuela to meet in Baghdad in an attempt to regain control over resources and establish a collective voice. That meeting led to the creation of the Organization of the Petroleum Exporting Countries, or OPEC. Over time, more countries joined, including the United Arab Emirates.
This did not eliminate volatility, but it introduced the possibility that supply could be managed, not just reacted to.
For decades, that idea has quietly underpinned how markets think about oil. A small group of producers, led largely by Saudi Arabia, could adjust output not just in response to demand, but to influence price itself. The system offered a degree of predictability, often enough for markets to assume oil would not move entirely unchecked.
That assumption has held even through disruption, including in the Strait of Hormuz in recent months due to the US-Israel war on Iran. Markets, in effect, continue to price oil as something that can still be stabilised.
Recent developments around OPEC, however, begin to complicate that view. The UAE this week decided to exit the group, introducing a new source of uncertainty around how supply will be managed going forward.
The UAE is among the larger producers in the group – and one of the few with spare capacity. Its decision to leave OPEC, effective May 1, frees it from production quotas designed to balance supply. Over time, this could allow it to increase output more independently, particularly once logistical constraints ease.
For now, those constraints matter. The war in the Middle East has reduced flows through key routes, limiting the immediate impact of any policy shift. The UAE’s signal, then, is less about the present and more about what may follow.
OPEC’s influence has always depended on coordination. Its ability to shape prices came not just from production volumes, but from discipline – members acting together rather than competing for market share. The UAE’s exit raises the possibility that this discipline could loosen over time, potentially reducing the group’s ability to manage supply.
That, in turn, may begin to change how oil prices move. A coordinated system tends to dampen volatility. A more fragmented one, where producers act independently, does not. It opens up a wider range of outcomes, where prices respond more directly to shifts in supply, demand and geopolitics, rather than managed responses.
Markets have not fully adjusted to that shift yet. Prices still reflect disruption more than structure. But the balance of forces is beginning to evolve. If producers increasingly prioritise market share over coordination, the ability of any one country, even Saudi Arabia, to act as a stabilising force becomes less certain.
The implications extend beyond oil. For inflation, it means a key input may become harder to anchor. For central banks, including the Reserve Bank of India, it complicates the task of interpreting price pressures. And for markets, it introduces a wider range of outcomes, where stability can give way more quickly to sharper adjustments.
In India, which imports 85-90% of its crude, this matters directly. Oil influences inflation, growth, and fiscal and monetary policies. What may change is not just prices, but also their reliability and creates a more uncertain macro environment.
Whether this is an isolated shift or the early sign of a broader loosening of discipline is unclear. The question is less about whether oil will rise or fall, and more about how it will be priced if coordination itself becomes less certain.
Prescription for Expansion
After global oil developments, let’s move our lens to the local pharma sector.
For a while, India’s pharma sector has settled into a predictable pattern marked by steady earnings, but limited ambition. That backdrop makes the recent move by Sun Pharmaceutical Industries stand out.
Sun Pharma has agreed to acquire US-based Organon in an all-cash deal valued at about $1.75 billion. This is the largest overseas acquisition by an Indian pharma company in recent years. The acquisition gives Sun Pharma access to Organon’s portfolio of established drugs across therapeutic areas, along with a presence in multiple international markets.
On the surface, this may look like a straightforward expansion: buying scale, diversifying revenue, and strengthening global presence. But deep down it is the timing that matters.
For years, Indian pharma has been navigating a difficult balance. Pricing pressure in key markets like the US, regulatory scrutiny and a shift toward complex generics have made growth less predictable. Companies responded by becoming more cautious, focusing on compliance, balance sheets and incremental gains rather than large bets.
This deal suggests that approach may be shifting.
Sun Pharma is deploying capital at scale, and doing so in cash. That signals confidence not just in its balance sheet, but in the visibility of future cash flows. It also reflects a willingness to look beyond organic growth at a time when the sector’s traditional engines are under pressure. But it raises two broad questions:
- Is this a response to limited growth within the existing model?
- Is a recognition of that scale and diversification now necessary to sustain returns?
The nature of the assets being acquired adds another layer. Established drug portfolios can provide stable cash flows, but they do not always offer high growth. The trade-off between stability and growth becomes central, and markets will likely watch how that balance evolves.
There is also the question of execution. Large acquisitions in pharma are not just financial transactions, they involve regulatory alignment, supply chains and portfolio integration. The outcome will depend as much on execution as on strategy.
For the sector, too, the signal is important. If the largest player is willing to pursue a sizable global acquisition, it may indicate a gradual return of risk appetite. That, in turn, could influence how other companies approach capital allocation.
For investors, the takeaway is less about this one deal and more about what it might represent.
It’s too early to say whether this is the beginning of a broader shift in how Indian pharma approaches growth. But it does suggest the sector may be moving toward a phase where stability alone is no longer sufficient, and where the next leg of growth could depend on how willing companies are to move beyond it.
Buffers and Balance Sheets
Moving on from pharmaceuticals to banking, India’s top lenders have declared fourth-quarter and FY26 results. At first glance, the Q4 numbers from HDFC Bank, ICICI Bank and Axis Bank look steady. Profits have grown, asset quality has improved and capital positions remain comfortable.
HDFC Bank reported a net profit of Rs 19,221 crore, up about 9% year-on-year, with stable net interest income and improving asset quality. ICICI Bank posted an 8.5% rise in profit to Rs 13,701 crore, alongside plans to raise capital through domestic and overseas debt markets. Axis Bank’s profit was broadly flat but it increased provisions sharply, including a one-time buffer of over Rs 2,000 crore.
Taken together, these results do not point to stress. But they do not point to acceleration either.
For a while, the narrative around Indian banking has been one of clean-up and recovery: bad loans falling, balance sheets strengthening and credit growth returning. That phase is largely behind us. What the fourth-quarter numbers suggest is something more measured: stability, with a degree of caution.
Axis Bank’s decision to build additional provisions, despite stable asset quality, is particularly telling. The bank’s reference to “unpredictable macroeconomic and geopolitical conditions” suggests this is less about current stress and more about managing future risk, at a time when the global macroeconomic scenario and commodity prices have become volatile.
The other large banks are not saying this as explicitly, but their actions point in a similar direction. Capital raising plans, steady margins and controlled growth suggest a system positioning itself carefully rather than expanding aggressively.
This creates a contrast. Credit growth, especially in corporate and SME segments, remains strong. Yet, profitability is not expanding at the same pace, and banks appear to be strengthening buffers rather than fully deploying capital.
That raises a broader question: Are banks preparing for a turn in the cycle, or adjusting to an uncertain environment?
For investors, the takeaway is more about posture. Banks are not signalling stress, but neither are they behaving as if conditions are entirely benign. The emphasis appears to be shifting from growth to resilience.
Markets often focus on outcomes. This quarter is more about intent. And the intent, at least for now, appears to be to stay prepared rather than to push ahead.
On Cloud Nine
While India’s biggest banks maybe preparing for uncertainties, at the other end of the pond the globe’s largest tech companies are moving confidently forward with no signs of doubts whatsoever.
Five of the “Magnificent Seven” Big Tech companies reported their first-quarter earnings this week, mostly exceeding market forecasts and highlighting the massive spending on artificial intelligence initiatives.
Google parent Alphabet’s total revenue rose 22% to $109.9 billion in the first quarter, beating estimates. Its consolidated operating income increased 30% to $39.7 billion and net income surged 81% to $62.6 billion. Amazon’s revenue grew 17% to $181.5 billion and net income jumped 77% to $30.3 billion. Meta’s revenue surged 33% to $56.31 billion while Microsoft’s topline grew 18% to $82.9 billion and iPhone maker Apple Inc’s revenue rose 16% to $143.8 billion.
The companies also reported strong growth in their cloud-computing revenue in the March quarter—Google Cloud’s topline surged 63%, Microsoft’s Azure was up 40% and Amazon Web Services posted a 28% increase.
More importantly, these companies also forecast strong capex outlays for AI projects in coming quarters that are now set to touch $725 billion this year from $600 billion previously.
Microsoft unveiled plans to spend $190 billion in fiscal year 2026; Alphabet raised this year’s forecast to $180-190 billion, up $5 billion announced in last quarter; and Meta lifted its capex forecast to $125-145 billion, from $115-135 billion. Amazon maintained its target for $200 billion in AI investment this year.
Meanwhile, some of these companies are also laying off employees. Meta will reduce its headcount by 10% this year while Microsoft has offered voluntary retirement to 7% of its staff.
For now, these tech giants are projecting confidence about their AI investments as their cloud revenue climbs. But some investors remain skeptical, as was evident from Meta shares slumping over 8% after it lifted its capex. Whether the massive AI spending will lead to higher revenue and profits on a sustained basis, that’s a little too soon to call.
Earnings Snapshot
- Hindustan Unilever profit rises 18% to Rs 2,930 crore on price hikes, cost cuts
- Bajaj Finance posts 22% rise in Q4 profit to Rs 5,465 crore
- Reliance Industries Q4 consolidated net profit falls to Rs 16,971 crore, misses market forecasts
- Adani Enterprises Q4 consolidated net loss Rs 221 crore vs year-ago profit of Rs 3,845 crore
- Adani Power profit jumps 52% to Rs 4,017 crore on one-time tax gain of Rs 793 crore
- Adani-owned ACC’s Q4 profit slumps 66% to Rs 249 crore
- State-run NALCO’s Q4 net profit falls 16.6% to Rs 1,722 crore
- Vedanta reports 92.3% jump in quarterly profit to Rs 6,698 crore
- UltraTech Q4 consolidated net profit rises 20.2% to Rs 2,983 crore
Other Headlines
- India, New Zealand sign free trade agreement; cut fruit tariffs, boosts exports and visas
- Standard Chartered to sell 4.5 lakh Indian credit cards out of 6.4 lakh to Federal Bank
- Govt cuts Vodafone Idea’s long-pending dues to Rs 64,046 crore from Rs 87,695 crore
- Renault rejigs India ops; to house powertrain manufacturing and vehicle manufacturing into separate entities
- Foreign portfolio investors pull out $20 billion in Jan-April 2026; surpass last year’s annual exit
- Govt proposes rules to allow 85% ethanol-blended fuels and 100% ethanol in vehicles
- India’s March industrial production slows to five-month low of 4.1% on weak factory output, power generation
- Maruti Suzuki plans to invest $1.48 billion to expand manufacturing capacity
Interested in how we think about the markets?
Read more: Zen And The Art Of Investing
Watch here: Investing in International Markets
Start investing through a platform that brings goal planning and investing to your fingertips. Visit kuvera.in to discover Direct Plans and Fixed Deposits and start investing today. #MutualFundSahiHai #KuveraSabseSahiHai
